- Thread Author
- #1
Polish Biotech Firm Develops Promising mRNA Cancer Vaccine
Kraków-based startup NucleicBio published Phase I trial results for a personalized mRNA vaccine targeting colorectal cancer, showing a strong immune response with minimal side effects.
Kraków-based startup NucleicBio published Phase I trial results for a personalized mRNA vaccine targeting colorectal cancer, showing a strong immune response with minimal side effects.
